At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 440 enrolled
Drug / intervention
Bromfenac Ophthalmic Solution +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Efficacy and Safety of Bromfenac Ophthalmic Solution vs. Placebo for the Treatment of Ocular Inflammation and Pain Associated With Cataract Surgery.
In Brief
A Phase 3 clinical trial evaluating Bromfenac Ophthalmic Solution and Placebo for Pain and 2 related conditions. Completed, enrolled 440 participants across 1 site.
Detailed Summary
This is an efficacy study of Bromfenac Ophthalmic Solution in cataract surgery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Inflammation, Cataract
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartMay 2011
First PostedJun 2011
Primary CompletionJul 2011
Study CompletionDec 2011
TodayJul 2026
First PostedJun 7, 2011
Enrollment StartMay 1, 2011
Primary CompletionJul 1, 2011
Study CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 15.1 years ago
Interventions
Bromfenac Ophthalmic Solutiondrug
Sterile ophthalmic solution
Placebodrug
Sterile ophthalmic solution